FHTX
Foghorn Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.92
+1.03%Margins
Gross margin
42.7%
EBITDA margin
-170.1%
EBIT margin
-186.4%
Net margin
-175.8%
FCF margin
-232.3%
79.7%
Return on equity
-31.8%
Return on assets
180.5%
Return on invested capital
0.17x
Asset turnover
-$85.3M
Cash from operations
$2.82
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026